Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Thicker hair grows faster; hair loss patients have slower growth.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Health warnings and public health actions led to a significant drop in flutamide prescriptions for women, but off-label use still continues.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Valproate is a mood stabilizer for bipolar disorder but has side effects and risks, especially during pregnancy.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The document provides a method to classify human hair growth stages using a model with human scalp on mice, aiming to standardize hair research.

DHT stops hair regrowth in mice, similar to human hair loss.

Rice bran extract might help prevent hair loss.

Finasteride caused blisters on hands and feet.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Balding men had lower bone density, while balding women had higher hip bone density.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.